— Know what they know.
Not Investment Advice
Also trades as: IPN.PA (PAR) · $vol 18M · IPSEY (OTC) · $vol 0M

IPSEF OTC

Ipsen S.A.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -1.4% 5Y: +14.9%
$113.13
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 50 · $9.4B mcap · 34M float · 0.0001% daily turnover · Short 100% of daily vol

Cash Flow Trends

Operating Cash Flow
$1.1B +24.3% ▲
5Y CAGR: +8.1%
Capital Expenditures
$105M +86.5% ▲
5Y CAGR: -5.6%
Free Cash Flow
$1.0B +676.5% ▲
5Y CAGR: +10.4%
Dividends Paid
$116M -16.6% ▼
Buybacks
$68M -85.4% ▼
Net Change in Cash
$927M +486.6% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$647M$592M$617M$357M$443M
Depreciation & Amort.$237M$336M$88M$706M$356M
Stock-Based Comp.$27M$26M$30M$30M$0
Change in Working Capital-$32M-$39M$76M-$54M$300K
Other Non-Cash Items-$4M$86M$55M-$123M$182M
Operating Cash Flow$909M$971M$866M$916M$1.1B
— Investing Activities —
Capital Expenditures-$428M-$253M-$116M-$173M-$329M
Acquisitions (Net)-$14M-$139M-$916M-$65M-$341M
Investment Purchases-$28M-$8M$0$0-$2M
Investment Sales$360M$8M$0$0$0
Other Investing-$234M-$66M-$46M-$438M$57M
Investing Cash Flow-$344M-$459M-$1.1B-$677M-$615M
— Financing Activities —
Net Debt Issuance-$280M-$34M-$291M$44M$477M
Stock Repurchased-$37M-$11M-$40M-$36M-$68M
Dividends Paid-$83M-$99M-$100M-$100M-$116M
Other Financing-$2M-$19M-$6M-$8M$5M
Financing Cash Flow-$401M-$164M-$436M-$100M$298M
Net Change in Cash$170M$356M-$646M$158M$927M
Cash End of Period$809M$1.2B$520M$678M$1.5B
Free Cash Flow$482M$718M$683M$133M$1.0B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms